🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

299,00 USD

Máx. histórico

322,75

6 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-7,36%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-5,42%

Cierre anterior

316,13

Rango de hoy

297,63 – 318,98

Volumen hoy

247.610

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
120,08 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 3 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/10/2020 60,66 62,41 59,83 60,61 -1,07% 4,27% 335.348
01/10/2020 59,89 61,38 58,54 61,26 +3,02% 4,75% 299.601
30/09/2020 59,75 61,40 59,38 59,46 -0,50% 3,38% 239.007
29/09/2020 60,85 61,42 59,15 59,76 +0,05% 3,72% 402.513
28/09/2020 61,40 61,84 59,36 59,73 -1,47% 4,04% 307.616
25/09/2020 58,84 60,87 58,45 60,62 +3,03% 4,10% 345.767
24/09/2020 57,60 60,33 56,92 58,84 +1,22% 5,92% 775.692
23/09/2020 62,13 62,13 57,79 58,13 +4,04% 6,99% 1.250.340
22/09/2020 56,25 56,58 55,45 55,87 -0,46% 2,02% 406.361
21/09/2020 56,74 56,74 54,55 56,13 -2,29% 3,86% 744.433
18/09/2020 59,26 59,55 56,34 57,44 -2,20% 5,41% 640.078
17/09/2020 58,92 60,00 57,84 58,73 -1,09% 3,66% 308.578
16/09/2020 60,25 61,26 59,32 59,38 -0,83% 3,22% 316.913
15/09/2020 61,53 62,91 59,52 59,88 -2,33% 5,52% 593.591
14/09/2020 64,22 64,88 61,06 61,31 -3,43% 5,95% 612.346
11/09/2020 63,21 64,35 62,48 63,49 +1,75% 2,96% 484.106
10/09/2020 63,93 64,19 61,62 62,40 -1,01% 4,01% 588.141
09/09/2020 62,25 63,47 61,97 63,03 +1,96% 2,42% 337.271
08/09/2020 60,79 63,51 59,90 61,82 +0,03% 5,93% 585.416
04/09/2020 61,59 62,53 60,06 61,80 +0,34% 4,01% 462.466
03/09/2020 63,99 64,16 60,40 61,59 -4,35% 5,88% 394.498
02/09/2020 63,46 65,42 62,98 64,39 +1,40% 3,84% 317.073
01/09/2020 63,47 64,44 62,48 63,50 -0,21% 3,09% 360.675
31/08/2020 64,92 65,11 63,18 63,63 -1,21% 2,97% 282.769
28/08/2020 64,67 64,87 63,98 64,41 -0,13% 1,37% 199.093
27/08/2020 66,13 66,13 63,66 64,49 -1,89% 3,74% 310.181
26/08/2020 67,19 67,81 65,44 65,73 -2,80% 3,53% 268.503
25/08/2020 67,43 68,00 66,34 67,62 +0,93% 2,46% 231.634
24/08/2020 69,18 69,68 66,92 67,00 -4,09% 3,99% 307.616
21/08/2020 71,33 72,21 69,35 69,86 -2,63% 4,01% 262.251